These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25933205)

  • 1. AICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver.
    Liu S; Jing F; Yu C; Gao L; Qin Y; Zhao J
    PLoS One; 2015; 10(5):e0124951. PubMed ID: 25933205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
    J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMP-kinase pathway is involved in tumor necrosis factor alpha-induced lipid accumulation in human hepatoma cells.
    Lv Q; Zhen Q; Liu L; Gao R; Yang S; Zhou H; Goswami R; Li Q
    Life Sci; 2015 Jun; 131():23-9. PubMed ID: 25817233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The flavone apigenin blocks nuclear translocation of sterol regulatory element-binding protein-2 in the hepatic cells WRL-68.
    Wong TY; Lin SM; Leung LK
    Br J Nutr; 2015 Jun; 113(12):1844-52. PubMed ID: 25978649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexacosanol reduces plasma and hepatic cholesterol by activation of AMP-activated protein kinase and suppression of sterol regulatory element-binding protein-2 in HepG2 and C57BL/6J mice.
    Lee JH; Jia Y; Thach TT; Han Y; Kim B; Wu C; Kim Y; Seo WD; Lee SJ
    Nutr Res; 2017 Jul; 43():89-99. PubMed ID: 28676202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription.
    Yap F; Craddock L; Yang J
    Int J Biol Sci; 2011; 7(5):645-50. PubMed ID: 21647332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unripe
    Lee KH; Jeong ES; Jang G; Na JR; Park S; Kang WS; Kim E; Choi H; Kim JS; Kim S
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32110925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
    Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
    Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid-stimulating hormone decreases HMG-CoA reductase phosphorylation via AMP-activated protein kinase in the liver.
    Zhang X; Song Y; Feng M; Zhou X; Lu Y; Gao L; Yu C; Jiang X; Zhao J
    J Lipid Res; 2015 May; 56(5):963-71. PubMed ID: 25713102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor α-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated protein kinase-independent.
    Bumpus NN; Johnson EF
    J Pharmacol Exp Ther; 2011 Dec; 339(3):886-95. PubMed ID: 21896918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine suppresses AMP-activated protein kinase signaling pathway to promote hepatic lipid accumulation in primary mouse hepatocytes.
    Xiong J; Yang H; Wu L; Shang W; Shan E; Liu W; Hu G; Xi T; Yang J
    Int J Biochem Cell Biol; 2014 Sep; 54():236-44. PubMed ID: 25102273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
    Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated AMPK explains hypolipidemic effects of sulfated low molecular weight guluronate on HepG2 cells.
    Liu X; Hao JJ; Zhang LJ; Zhao X; He XX; Li MM; Zhao XL; Wu JD; Qiu PJ; Yu GL
    Eur J Med Chem; 2014 Oct; 85():304-10. PubMed ID: 25089813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes.
    Xie Z; Zhang J; Wu J; Viollet B; Zou MH
    Diabetes; 2008 Dec; 57(12):3222-30. PubMed ID: 18835932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of hepatocytic AMP-activated protein kinase by okadaic acid and other autophagy-suppressive toxins.
    Samari HR; Møller MT; Holden L; Asmyhr T; Seglen PO
    Biochem J; 2005 Mar; 386(Pt 2):237-44. PubMed ID: 15461583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMP-activated protein kinase suppresses the expression of LXR/SREBP-1 signaling-induced ANGPTL8 in HepG2 cells.
    Lee J; Hong SW; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Lee WY
    Mol Cell Endocrinol; 2015 Oct; 414():148-55. PubMed ID: 26254015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver.
    Horike N; Sakoda H; Kushiyama A; Ono H; Fujishiro M; Kamata H; Nishiyama K; Uchijima Y; Kurihara Y; Kurihara H; Asano T
    J Biol Chem; 2008 Dec; 283(49):33902-10. PubMed ID: 18801732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells.
    Egawa T; Ohno Y; Goto A; Ikuta A; Suzuki M; Ohira T; Yokoyama S; Sugiura T; Ohira Y; Yoshioka T; Goto K
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E344-54. PubMed ID: 24347059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underpinning AMP-activated protein kinase-related effects on behavior and hippocampal neurogenesis in an animal model of depression.
    Odaira T; Nakagawasai O; Takahashi K; Nemoto W; Sakuma W; Lin JR; Tan-No K
    Neuropharmacology; 2019 May; 150():121-133. PubMed ID: 30914305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway.
    Hwang YP; Kim HG; Choi JH; Do MT; Chung YC; Jeong TC; Jeong HG
    J Nutr Biochem; 2013 Aug; 24(8):1469-78. PubMed ID: 23465592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.